Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Severe mycotic pansinusitis in a patient with hairy cell leukemia, ending lethally

S. Markov, H. Halacheva, V. Goranova

Abstract

Hairy cell leukemia, HCL is the result of a mutation of B-memory lymphocytes from the germinal center with a low degree of malignancy, with an indolent course, slow progression and a very good therapeutic effect. Clinically, HCL is characterized by a tendency toward peripheral pancytopenia, discrete lymphoadenomegaly, and significant splenomegaly. The main reason for shortened survival, even in contemporary, is various infectious complications, especially opportunistic infections, mycotic, etc. They not only limit or compromise the therapeutic response, but also often lead to a fatal outcome.
We present a 42-year-old patient diagnosed with HCL in 2014 who underwent a significant number of specific courses of treatment, including splenectomy. In a subsequent recurrence, marked enlargement and thickening of the mucosa of the left maxillary, sphenoidal, frontal and ethmoidal sinuses, polypoidal mucosal hypertrophy with partial obstruction of the nasal passages, massive necrotic involvement of the soft tissues and bilateral thrombosis of the facial arteries were found. Histological examination confirmed mycotic hyphae. Aspergillus Flavus was verified microbiologically. Despite comprehensive conservative and surgical treatment, the disease ended fatally. Infectious complications (especially mycotic ones) are the result of severe quantitative and qualitative disorders in the main effector cell lines with pronounced granulocytopenia, monocytopenia, reduced activity of natural killers, T-helpers, poor antibody response even with normal immunoglobulins and reduced antibody-dependent cellular cytotoxicity. When such complications occur, patients require immediate action by an interdisciplinary team.

Keywords

Hairy cell leukemia, pansinusitis, infectious complications, aspergillosis

Full Text


References

Надежда Стефанова Мария Цанева; "Диагностични критерии и морфологична характеристикахна костния мозък при класическите PH (-) миелопролиферативни неоплазми съгласно последната ревизия на СЗО от 2016 г.; Варненски медицински форум, т. 6, 2017, брой 1

Герчева-Кючукова, Л. Хронични миелопролиферативни неоплазми. Първо издание. Плевен, ЕТ "Пейчински – Г. Илиев", 2016.

Mihaylov G, Grudeva-Popova Z, Slavcheva V, Tsvetkova G, Nikolov I, Ignatova K, Sapunarova K, Shemelekova L, Donchev M, Simeonov S, Varbanov H. Working group

"Lymphoid neoplasias at the BMS. Tricholeukemia. Hematology. Methodological guidelines for diagnosis and treatment of hematological diseases. 2015 (LI); 3-4:113-116)

Davidkova Ya., Balatsenko G., Vladimirova R., Dikov T., Madzharova V., Yagurinoski M., Spasov B., Genova M. Differential-diagnostic approach in classical tricholeukemia and other lymphomas with villous characteristics. Hematology 2020 (LVI); 1-2:43-54)

Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood. 1998;92:1918–26

Rosenberg JD, Burian C, Waalen J, Saven A. Clinical characteristics and long-term

outcome of young hairy cell leukemia patients treated with cladribine: a single institution series. Blood. 2014;123:177–83.

Mohammad Biglari1, Hosein Kamranzadeh Foumani, Maryam Bagherian, Bahram Chahardouli, Ardeshir Ghavamzadeh. Retrospective Evaluation of Hairy Cell Leukemia Patients: Analysis of a Long-Term Single Center Data.; IJHOSCR, 1 October. Volume 16, Number 4

Brunangelo Falini, Luca De Carolis, and Enrico Tiacci. How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors.; Blood 14 April 2022 | Volume 139, Number 15

Forconi F, Sozzi E, Cencini E, et al. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Blood. 2009; 114(21):4696-4702.

Kraut EH.; "Clinical manifestations and infectious complications of hairy-cell leukaemia. Kraut EH"; Best Pract Res Clin Haematol. 2003;16:33–40

Abdul Moiz Khan, Sheikh Raza Shahzad, Saleh Najjar, Llewellyn Foulke; "Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia"; Cureus. 2020 Jan;

Robert J. Kreitman; "Hairy cell leukemia: present and future directions"; Leuk Lymphoma. Author manuscript; available in PMC 2020 Aug 19. Published in final edited form as: Leuk Lymphoma. 2019 Dec; 60(12): 2869–2879. Published online 2019 May 9. doi: 10.1080/10428194.2019.1608536

Daniel Gorman, Adam Green, Nitin Puri, Phil Dellinger; "Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia"; J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10: 23247096211065618. Published online 2022 Jan17. doi: 10.1177/23247096211065618

Vassilios Papadopoulos, Charalambos Kartsios, Anastassia Spyrou, Kostas Loukidis, Spyridon Miyakis, Stavroula Pervana, Charalambos Makridis, Anna Kioumi, Ioannis Korantzis; "Isolated Splenic Mycobacterial Disease: A Cause of Persistent Fever in a Hairy Cell Leukemia Patient"; Case Rep Gastroenterol. 2010 Sep-Dec; 4(3): 330–334. Published online 2010 Sep 11. doi: 10.1159/000320639

Vahan Moradians, Bahareh Shateri Amiri, Leyla Bahadorizadeh, Milad Gholizadeh Mesgarha, Shahrzad Sadeghi; "Concurrent COVID-19 and pneumocystis carinii pneumonia in a patient subsequently found to have underlying hairy cell leukemia";

Radiol Case Rep. 2022 Sep; 17(9): 3238–3242. Published online 2022 Jul 2. doi: 10.1016/j.radcr.2022.06.026 PMCID: PMC9249992

ChandraMohan Ramasamy, Biswajit Dubashi, J. Sree Rekha, Debdatta Basu, Ankit Jain, Tarun Kumar Dutta; "Atypical Mycobacterial Infection in Hairy Cell Leukemia Treated with Cladribine"; Indian J Hematol Blood Transfus. 2014 Mar; 30(1): 59–61. Published online 2012 Oct 9. doi: 10.1007/s12288-012-0196-1

Daniel P. Shenoi, Leslie A. Andritsos, James S. Blachly, Kerry A. Rogers, Mollie E. Moran, Mirela Anghelina, Jeffrey A. Jones, Michael R. Grever; "Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib"; Blood Adv. 2019 Jan 22; 3(2): 116–118. Published online 2019 Jan 10. doi: 10.1182/bloodadvances.2018027466

Aref Shariati, Alireza Moradabadi, Zahra Chegini, Amin Khoshbayan, Mojtaba Didehdar; "An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies"; Infect Drug Resist. 2020; 13: 2329–2354. Published online 2020 Jul 14. doi: 10.2147/IDR. S254478

Berghi NO, Dumitru M, Vrinceanu D, Ciuluvica RC, Simioniuc Petrescu A, Caragheorgheopol R, Tucureanu C, Cornateanu RS and Giurcaneanu C: Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review). Exp Ther Med 20: 2352‑2360, 2020.

Stammberger H, Jakse R and Beaufort F: Aspergillosis of the paranasal sinuses; X‑ray diagnosis, histopathology, and clinical aspects. Ann Otol Rhinol Laryngol 93: 251‑256, 1984.

Rowe‑Jones JM and Moore‑Gillon V: Destructive noninvasive paranasal sinus aspergillosis: Component of a spectrum of disease. J Otolaryngol 23: 92‑96, 1994

Lee JH, Oh DH and Lee DH: A single small‑sized fungus ball in the maxillary sinus: An endoscopic view. Ear Nose Throat J 99: 165‑166, 2020., Adrian Costache, Toma Papacocea, Romica Cergan;

Daniela Vrinceanu, Mihai Dimitru, Oana Maria Patrascu Adrian Costache, Toma Papacocea, Romica Cergan; Current diagnosis and treatment of rhinosinusal aspergilloma (Review); Experimental and Therapeutic Medicine 22: 1264, 2021

Swu-Jane Lin, Jennifer Schranz, and Steven M. Teutsch; Aspergillosis Case-Fatality Rate: Systematic Review of the Literature; Clinical Infectious Diseases 2001; 32:358–66

Yeon Seok You, Ji Hoon Koh, Byeong Jin Kim, Eun Jung Lee, Sam Hyun Kwon, Jong Seung Kim; Life-Threatening Sinonasal Invasive Aspergillosis Easily Misdiagnosed; Korean J Otorhinolaryngol-Head Neck Surg 2023;66(4):234-40 / eISSN 2092-6529




DOI: http://dx.doi.org/10.14748/orl.v19i4.10007

Refbacks

Font Size


|